Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Merck
MRK
|
$446M |
| 2 |
NVIDIA
NVDA
|
$375M |
| 3 |
Apple
AAPL
|
$319M |
| 4 |
EXE
Expand Energy Corporation Common Stock
EXE
|
$317M |
| 5 |
Meta Platforms (Facebook)
META
|
$310M |
Top Sells
| 1 |
SWN
Southwestern Energy Company
SWN
|
$381M |
| 2 |
Exxon Mobil
XOM
|
$324M |
| 3 |
MRO
Marathon Oil Corporation
MRO
|
$223M |
| 4 |
SoFi Technologies
SOFI
|
$160M |
| 5 |
VSTO
Vista Outdoor Inc.
VSTO
|
$136M |
Sector Composition
| 1 | Technology | 20.48% |
| 2 | Financials | 18.31% |
| 3 | Industrials | 12.31% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Lightbridge
LTBR
$366M
| $90.1K | ﹤0.01% |
19,038
-19,279
| -50% | -$91.2K |
|
3252
Phunware
PHUN
$49.9M
| $88.5K | ﹤0.01% |
+17,027
| New | +$88.5K |
|
3253
Ovid Therapeutics
OVID
$91.7M
| $86.9K | ﹤0.01% |
92,971
-11,040
| -11% | -$10.3K |
|
3254
Sangamo Therapeutics
SGMO
$160M
| $86K | ﹤0.01% |
84,270
-409,416
| -83% | -$418K |
|
3255
Barnwell Industries
BRN
$11.6M
| $84.1K | ﹤0.01% |
55,713
-7,529
| -12% | -$11.4K |
|
3256
BRF SA
BRFS
$5.88B
| $81.8K | ﹤0.01% |
20,096
-8,129
| -29% | -$33.1K |
|
3257
Astrotech Corp
ASTC
$8.45M
| $80.2K | ﹤0.01% |
11,930
+1,579
| +15% | +$10.6K |
|
3258
Journey Medical
DERM
$186M
| $80K | ﹤0.01% |
+20,455
| New | +$80K |
|
3259
Blink Charging
BLNK
$117M
| $79K | ﹤0.01% |
+56,851
| New | +$79K |
|
|
ICAD
3260
DELISTED
iCAD Inc
ICAD
| $78.2K | ﹤0.01% |
42,631
-6,468
| -13% | -$11.9K |
|
3261
RAVE Restaurant Group
RAVE
$47.5M
| $77.9K | ﹤0.01% |
30,449
+6,682
| +28% | +$17.1K |
|
|
AZUL
3262
DELISTED
Azul
AZUL
| $76.7K | ﹤0.01% |
45,602
+433
| +1% | +$729 |
|
3263
Energy Vault
NRGV
$335M
| $76.7K | ﹤0.01% |
33,637
+22,528
| +203% | +$51.4K |
|
3264
Stabilis Solutions
SLNG
$69.7M
| $76.6K | ﹤0.01% |
14,310
+1,531
| +12% | +$8.19K |
|
3265
Shattuck Labs
STTK
$72.3M
| $76.1K | ﹤0.01% |
62,956
-109,300
| -63% | -$132K |
|
3266
Lisata Therapeutics
LSTA
$18.1M
| $75.2K | ﹤0.01% |
25,226
+7,886
| +45% | +$23.5K |
|
3267
ImmunityBio
IBRX
$2.26B
| $71.6K | ﹤0.01% |
27,966
+16,954
| +154% | +$43.4K |
|
3268
Zevia
ZVIA
$199M
| $68K | ﹤0.01% |
16,239
| – | – |
|
3269
Usio Inc
USIO
$37.6M
| $67.8K | ﹤0.01% |
46,421
| – | – |
|
3270
SOPHiA GENETICS
SOPH
$230M
| $67.6K | ﹤0.01% |
21,619
+4,115
| +24% | +$12.9K |
|
3271
NextCure
NXTC
$13.2M
| $66.2K | ﹤0.01% |
7,154
| – | – |
|
3272
Cineverse
CNVS
$72.1M
| $65.5K | ﹤0.01% |
+17,952
| New | +$65.5K |
|
|
NKLA
3273
DELISTED
Nikola Corporation Common Stock
NKLA
| $65.1K | ﹤0.01% |
54,724
-12,522
| -19% | -$14.9K |
|
3274
Copel
ELPC
$6B
| $64.1K | ﹤0.01% |
12,181
-98
| -0.8% | -$516 |
|
3275
Precigen
PGEN
$1.36B
| $63.4K | ﹤0.01% |
57,082
| – | – |
|